Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

High Diagnostic Value of Anticalpastatin Autoantibodies in Rheumatoid Arthritis Detected by ELISA Using Human Erythrocyte Calpastatin as Antigen

SACHIKO IWAKI-EGAWA, HIROAKI MATSUNO, KAZUO YUDOH, FUJIO NAKAZAWA, KYOUSUKE MIYAZAKI, AKIRA OCHIAI, SHUNSEI HIROHATA, MASATOSHI SHIMIZU, and YASUHIRO WATANABE

ABSTRACT.

Objective.
To develop a quantitative method of measuring autoantibodies against human calpastatin in rheumatoid arthritis (RA) and to determine their diagnostic value compared with other autoimmune and articular diseases.

Methods. We performed a highly sensitive ELISA for IgG and IgM anticalpastatin autoantibodies in human sera using human erythrocyte calpastatin as an antigen. Samples were diluted 1:2000 for the measurement of IgG and 1:400 for IgM.

Results. IgG anticalpastatin antibodies were found in the sera of 48 of 58 patients (82.8%) with RA. In contrast, IgG anticalpastatin antibodies were found in the sera of only 2 of 11 (8.3%) patients with osteoarthritis (OA). Compared to sera from patients with other autoimmune diseases, anticalpastatin antibody sensitivity for RA was better than that of systemic lupus erythematosus (5.6%), systemic sclerosis (0%), mixed connective tissue disease (0%), and Sjögren's syndrome (20%). IgG anticalpastatin antibodies also showed high specificity (96.1%) for RA. Almost 90% of patients with RA were positive for IgG or IgM anticalpastatin antibodies.

Conclusion. We have developed a simple, sensitive, specific, and quantitative ELISA for anticalpastatin antibodies that may have a high diagnostic value for RA. (J Rheumatol 2004;31:17-22)

Key Indexing Terms:

RHEUMATOID ARTHRITIS
ANTICALPASTATIN AUTOANTIBODIES
ERYTHROCYTE
CALPASTATIN
ELISA


From the Department of Pathological Biochemistry, Hokkaido College of Pharmacy, Otaru; Department of Orthopedic Surgery, Toyama Medical and Pharmaceutical University, Toyama; Seikagaku Corporation, and the Department of Internal Medicine, Teikyo University School of Medicine, Tokyo; and Hino Hospital, Osaka, Japan.

S. Iwaki-Egawa, PhD, Assistant Professor; Y. Watanabe, PhD, Professor, Pathological Biochemistry, Hokkaido College of Pharmacy; F. Nakazawa, MD, PhD, Department of Orthopedic Surgery, Toyama Medical and Pharmaceutical University; K. Miyazaki, PhD; A. Ochiai, PhD, Seikagaku Corporation; S. Hirohata, MD, PhD, Associate Professor, Department of Internal Medicine, Teikyo University School of Medicine; M. Shimizu, MD, PhD, Hino Hospital; H. Matsuno, MD, PhD, current appointment: Professor, Department of Biomedical Engineering, Toin University of Yokohama; K. Yudoh, MD, PhD, current appointment: Lecturer, Department of Bioregulation, Institute of Medical Science, St. Marianna University of Medicine, Kawasaki.

Address reprint requests to Dr. S. Iwaki-Egawa, Department of Pathological Biochemistry, Hokkaido College of Pharmacy, 7-1 Katsuraoka-cho, Otaru 047-0264, Japan. E-mail: sachiko@hokuyakudai.ac.jp

Submitted January 28, 2003; revision accepted June 27, 2003.




Return to January 2004 Table of Contents



© 2004. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.